Skip to main content
HIMS
NYSE Industrial Applications And Services

Hims & Hers Completes Eucalyptus Acquisition, Expands Global Health Platform

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$27.99
Mkt Cap
$6.193B
52W Low
$13.74
52W High
$70.43
52W Position info
104% above low
Off High info
60% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

HIMS has more than doubled off its 52-week low of $13.74.

Summary

Hims & Hers Health, Inc. completed its acquisition of Eucalyptus, significantly expanding its international presence and reinforcing its position as a global consumer health platform, supported by an amendment to its credit agreement.


Key Events · M&A and Partnerships · HIMS

  • Acquisition Completed

    Hims & Hers Health, Inc. announced the completion of its acquisition of EUC Management Pty Ltd (d/b/a Eucalyptus), an Australian digital health platform.

  • Global Platform Expansion

    This acquisition, combined with previous deals, establishes Hims & Hers as a leading consumer health platform across the US, UK, Australian, and Canadian markets, with a growing presence in Europe and Japan.

  • Reinforces Long-Term Targets

    The company stated this global expansion reinforces its confidence in achieving long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030.

  • Credit Agreement Amended

    Hims & Hers amended its Revolving Credit and Guaranty Agreement to facilitate the Eucalyptus acquisition, including a grace period for covenant compliance and increased downstream investment capacity in non-loan party subsidiaries.


Analysis · HIMS · Industrial Applications And Services

Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, a strategic move to significantly expand its international footprint and customer base. This acquisition, following previous deals, positions the company as a leading global consumer health platform and is expected to contribute to its long-term revenue and Adjusted EBITDA targets. The company also amended its revolving credit agreement to facilitate the acquisition, including adjusting covenants and increasing investment capacity in non-loan party subsidiaries.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HIMS was trading at $27.99 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $13.74 to $70.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $15.13 info
Change: -$3.87 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $15.13 info
Change: -$3.71 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $15.13 info
Change: -$7.03 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $15.13 info
Change: -$7.20 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $15.13 info
Change: -$8.26 (-35%) info
Market Cap: $3.422B info